Dr. Shinohara on Radiation Therapy Considerations in Prostate Cancer

Video

In Partnership With:

Eric Shinohara, MD, MSCI, discusses radiation therapy considerations for patients with prostate cancer.

Eric Shinohara, MD, MSCI, associate professor and interim chair, Vanderbilt University Medical Center, discusses radiation therapy considerations for patients with prostate cancer.

When considering the types of radiation therapy options available for patients with prostate cancer, other health conditions and urinary function are often considered. Often times, other forms of radiation can be longer, taking 5 weeks or 9 weeks, and sometimes that can affect a patient's urination function a bit more. When speaking with a patient about the different types of radiation they could potentially receive, comorbidities and urinary function are factored into the decision, as well as the size of their prostate gland, concludes Shinohara.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,